1. A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma. (September 2017) Authors: Vergote, Ignace B.; Smith, David C.; Berger, Raanan; Kurzrock, Razelle; Vogelzang, Nicholas J.; Sella, Avishay; Wheler, Jennifer; Lee, Yihua; Foster, Paul G.; Weitzman, Ron; Buckanovich, Ronald J. Journal: European journal of cancer Issue: Volume 83(2017) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience. Issue 1 (May 2015) Authors: Fu, Siqing; Shi, Naiyi; Wheler, Jennifer; Naing, Aung; Janku, Filip; Piha-Paul, Sarina; Gong, Jing; Hong, David; Tsimberidou, Apostolia; Zinner, Ralph; Subbiah, Vivek; Hou, Ming-Mo; Ramirez, Pedro; Ramondetta, Lois; Lu, Karen; Meric-Bernstam, Funda Journal: Gynecologic oncology research and practice Issue: Volume 2:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018). Issue 1 (13th February 2019) Authors: Berry, Sneha; Giraldo, Nicolas; Nguyen, Peter; Green, Benjamin; Xu, Haiying; Ogurtsova, Aleksandra; Soni, Abha; Succaria, Farah; Wang, Daphne; Roberts, Charles; Stein, Julie; Engle, Elizabeth; Pardoll, Drew; Anders, Robert; Cottrell, Tricia; Taube, Janis M.; Tran, Ben; Voskoboynik, Mark; Kuo, Jam... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors. Issue 1 (December 2017) Authors: Dembla, Vikas; Groisberg, Roman; Hess, Ken; Fu, Siqing; Wheler, Jennifer; Hong, David; Janku, Filip; Zinner, Ralph; Piha-Paul, Sarina; Ravi, Vinod; Benjamin, Robert; Patel, Shreyaskumar; Somaiah, Neeta; Herzog, Cynthia; Karp, Daniel; Roszik, Jason; Meric-Bernstam, Funda; Subbiah, Vivek Journal: Scientific reports Issue: Volume 7:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PCI-24781, a Novel Hydroxamic Acid HDAC Inhibitor, Exerts Cytotoxicity and Histone Alterations via Caspase-8 and FADD in Leukemia Cells. (6th December 2009) Authors: Rivera-Del Valle, Nilsa; Gao, Shan; Miller, Claudia P.; Fulbright, Joy; Gonzales, Carolina; Sirisawad, Mint; Steggerda, Susanne; Wheler, Jennifer; Balasubramanian, Sriram; Chandra, Joya Other Names: Fulda Simone Academic Editor. Journal: International journal of cell biology Issue: Volume 2010(2010) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase I Dose‐Escalation Study of Pilaralisib (SAR245408, XL147) in Combination with Paclitaxel and Carboplatin in Patients with Solid Tumors. (8th March 2017) Authors: Wheler, Jennifer; Mutch, David; Lager, Joanne; Castell, Christelle; Liu, Li; Jiang, Jason; Traynor, Anne M. Journal: Oncologist Issue: Volume 22:Number 4(2017) Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase I Dose‐Escalation Study of Pilaralisib (SAR245408, XL147) in Combination with Paclitaxel and Carboplatin in Patients with Solid Tumors. (April 2017) Authors: Wheler, Jennifer; Mutch, David; Lager, Joanne; Castell, Christelle; Liu, Li; Jiang, Jason; Traynor, Anne M. Journal: Oncologist Issue: Volume 22:Number 4(2017) Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗